SH/EAHP 2007 Workshop - Progress in T-cell and NK cell Malignancies - title graphic

Cases by Session

Cases by Contact Submitter

Submitter Contact Information

Session 5. Therapy-related myeloid neoplasm

Session Chair Presented Case
Czader - Presentation Link
Presented Cases
  • 014:
AML/MDS, therapy related.
  • 032:
Markedly hypercellular marrow (95-100%) with dyserythroid hypoplasia, myeloid and dysmegakaryocytic hyperplasia, 4% blasts, increased eosinophils and basophils evolving into myelodysplastic/myeloproliferative disorder.
  • 057:
Acute myeloid leukemia, therapy-related, arising from donor-derived marrow.
Plasma cell myeloma, persistent.
  • 086:
Acute myeloid leukemia with t(9;11)(p22;q23) abnormality and metastatic Ewing sarcoma involving the bone marrow.
  • 089:
SM-AHNMD: Systemic mastocytosis with associated t(8;21)(q22;q22) AML.
  • 176:
Therapy-related AML/MDS with Philadelphia chromosome.
  • 183:
Diagnosis: Acute erythroid leukemia, subtype pure erythroid leukemia, M6b.
  • 188:
Acute promyelocytic leukemia, therapy related (t-ANLL).
Other Cases in the Session
  • 034:
 MDS/AML therapy related.
  • 040:
 Myelodysplastic syndrome with multilineage dysplasia, possibly therapy related due to previous therapy for AML. The decrease in MCV with demonstration of Hb H inclusions on supravital staining is consistent with acquired alpha thalassemia.
  • 144:
 Concurrent CLL with therapy-related AML (t-AML).
  • 156:
 MDS/AML, therapy related.
  • 206:
 Secondary (therapy-related) AML, pure erythroid differentiation.

Back to Top

Back to Cases by Session